OPKO Health, Inc.

LSE:0KCS Stock Report

Market Cap: US$1.0b

OPKO Health Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0KCS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyUS$199,375Phillip FrostIndividual125,000US$1.60
11 Dec 24BuyUS$781,050Phillip FrostIndividual500,000US$1.56
29 Nov 24BuyUS$305,376Phillip FrostIndividual199,072US$1.53
22 Nov 24BuyUS$159,000Phillip FrostIndividual100,000US$1.59
14 Nov 24BuyUS$161,980Phillip FrostIndividual100,000US$1.62
08 Nov 24BuyUS$421,535Phillip FrostIndividual280,183US$1.50
23 May 24BuyUS$126,937Phillip FrostIndividual100,000US$1.27
17 May 24BuyUS$211,195Phillip FrostIndividual163,997US$1.29
18 Mar 24BuyUS$437,100Phillip FrostIndividual500,000US$0.87
14 Mar 24BuyUS$444,300Phillip FrostIndividual500,000US$0.89
13 Mar 24BuyUS$463,750Phillip FrostIndividual500,000US$0.93
12 Mar 24BuyUS$559,380Phillip FrostIndividual600,000US$0.93
28 Feb 24BuyUS$496,150Phillip FrostIndividual500,000US$0.99
21 Feb 24BuyUS$991,700Phillip FrostIndividual1,000,000US$0.99
07 Feb 24BuyUS$1,462,800Phillip FrostIndividual1,500,000US$0.98
29 Jan 24BuyUS$29,838Richard KrasnoIndividual30,000US$0.99
19 Jan 24BuyUS$488,650Phillip FrostIndividual500,000US$0.98
18 Jan 24BuyUS$386,200Phillip FrostIndividual400,000US$0.97
17 Jan 24BuyUS$142,500Jane HsiaoIndividual150,000US$0.95
16 Jan 24BuyUS$954,300Phillip FrostIndividual1,000,000US$0.95
11 Jan 24BuyUS$480,379Phillip FrostIndividual511,531US$0.94
08 Jan 24BuyUS$99,884Gary NabelIndividual107,489US$0.93
08 Jan 24BuyUS$100,543Nabel Family Investments Llc,Company108,695US$0.93
05 Jan 24BuyUS$23,429Richard PfennigerIndividual25,000US$0.95
05 Jan 24BuyUS$8,669Steven RubinIndividual10,000US$0.87
05 Jan 24BuyUS$22,080John PaganelliIndividual25,000US$0.88
05 Jan 24BuyUS$514,093Elias ZerhouniIndividual550,300US$0.94
05 Jan 24BuyUS$1,344,600Phillip FrostIndividual1,500,000US$0.90
05 Jan 24BuyUS$130,899Jane HsiaoIndividual150,010US$0.87

Insider Trading Volume

Insider Buying: 0KCS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0KCS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,128,9562.99%
Hedge Funds48,706,6407.24%
General Public102,044,46215.2%
Institutions153,991,60322.9%
Individual Insiders347,928,60951.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.6%
Phillip Frost
246,232,605US$371.8m0.74%no data
7.24%
Rubric Capital Management LP
48,706,640US$73.5m9.64%1.39%
5.99%
Gary Nabel
40,308,686US$60.9m0.55%no data
4.92%
Jane Hsiao
33,127,284US$50.0m0%no data
4.34%
The Vanguard Group, Inc.
29,218,150US$44.1m3.46%no data
4.25%
BlackRock, Inc.
28,599,298US$43.2m-2.21%no data
3.03%
Elias Zerhouni
20,417,414US$30.8m0%no data
2.94%
Eaz Zeraz Trust
19,777,514US$29.9m0%no data
1.3%
State Street Global Advisors, Inc.
8,715,510US$13.2m-8.72%no data
1.24%
Geode Capital Management, LLC
8,374,745US$12.6m-5.1%no data
0.94%
Migdal Mutual Funds Ltd.
6,337,862US$9.6m10.4%0.08%
0.92%
Steven Rubin
6,187,732US$9.3m0%no data
0.88%
Invesco Capital Management LLC
5,917,439US$8.9m-8.26%no data
0.63%
Charles Schwab Investment Management, Inc.
4,212,355US$6.4m-16.6%no data
0.53%
Northern Trust Global Investments
3,532,927US$5.3m-13.9%no data
0.42%
Phillip and Patricia Frost Philanthropic Foundation, Inc, Endowment Arm
2,851,830US$4.3m0%100.0%
0.38%
Medical Strategy GmbH, Asset Management Arm
2,565,129US$3.9m0%0.25%
0.37%
Citadel Advisors LLC
2,501,674US$3.8m627%no data
0.37%
Millennium Management LLC
2,476,144US$3.7m96.3%no data
0.35%
Dimensional Fund Advisors LP
2,328,580US$3.5m-12.3%no data
0.31%
Voya Investment Management LLC
2,070,713US$3.1m-31%no data
0.25%
More Investment House Ltd.
1,713,845US$2.6m16.7%0.08%
0.25%
Goldman Sachs Group, Investment Banking and Securities Investments
1,685,981US$2.5m-16.4%no data
0.22%
Assenagon Asset Management S.A.
1,490,992US$2.3m143%no data
0.22%
UBS Asset Management AG
1,451,482US$2.2m2.2%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 00:34
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OPKO Health, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PetuskyBarrington Research Associates, Inc.
Louise ChenCantor Fitzgerald & Co.
Dana FlandersGuggenheim Securities, LLC